It is one of several blood cancers that causes abnormally high monocytes, a type of white blood cell. Symptoms of CMML ...

According to researchers at The University of Texas MD Anderson Cancer Center, 80% of patients with previously untreated or ...

Pivekimab sunirine is a monoclonal antibody conjugated commercialized by AbbVie, with a leading Phase II program in Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia).

9月13日，宜明昂科-B（01541.HK）继续狂飙，盘中一度大涨61.7%，位列港股涨幅榜第一。截至发稿前，该股涨幅有所收窄，为28.65%，报4.94港元/股。

As the First-Line Treatment in Adults with Chronic Myelomonocytic Leukemia（CMML） Timdarpacept（IMM01）联合阿扎胞苷（AZA）作为成人慢性粒-单核细胞白血病（CMML）一线治疗的疗效和安全性：一项II期研究汇报讲者 ...

经过3年深度回调后，目前港股医药板块估值整体正处于历史低位，严重压低了板块内企业的估值及流动性。而9月美联储启动降息已成定局，将为港股生物医药板块带来期待已久的流动性。

9月13日，宜明昂科-B（ 01541.HK ）继续狂飙，盘中一度大涨61.7%，位列港股涨幅榜第一。截至发稿前，该股涨幅有所收窄，为28.65%，报4.94港元/股。